OL
AZN icon

Optas LLC’s AstraZeneca AZN Stock Holding History

Optas LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
6,859
+20
+0.3% +$3.76K 0.18% 65
2026
Q1 		$1.35M Sell
6,839
-90
-1% -$17.4K 0.2% 59
2025
Q4 		$1.27M Sell
6,929
-614
-8% -$108K 0.2% 58
2025
Q3 		$1.16M Buy
7,543
+54
+0.7% +$8.17K 0.2% 62
2025
Q2 		$1.05M Sell
7,489
-298
-4% -$41.8K 0.2% 63
2025
Q1 		$1.14M Buy
7,787
+114
+1% +$16.5K 0.2% 55
2024
Q4 		$1.01M Sell
7,673
-112
-1% -$15.7K 0.22% 60
2024
Q3 		$1.21M Buy
7,785
+4,938
+173% +$797K 0.28% 52
2024
Q2 		$444K Buy
2,847
+673
+31% +$101K 0.11% 102
2024
Q1 		$295K Sell
2,174
-369
-15% -$48.9K 0.08% 142
2023
Q4 		$343K Buy
2,543
+209
+9% +$27.2K 0.1% 118
2023
Q3 		$316K Buy
2,334
+263
+13% +$35.9K 0.11% 112
2023
Q2 		$296K Buy
2,071
+158
+8% +$23.2K 0.1% 121
2023
Q1 		$265K Sell
1,913
-110
-5% -$14.8K 0.09% 131
2022
Q4 		$274K Sell
2,023
-197
-9% -$24.7K 0.11% 117
2022
Q3 		$242K Buy
2,220
+436
+24% +$55.3K 0.11% 115
2022
Q2 		$236K Buy
1,784
+238
+15% +$31.2K 0.1% 121
2022
Q1 		$205K Sell
1,546
-166
-10% -$19.9K 0.07% 141
2021
Q4 		$200K Buy
+1,712
New +$201K 0.06% 142
2020
Q4 		– Sell
-2,504
Closed -$275K – 143
2020
Q3 		$275K Buy
+2,504
New +$279K 0.08% 133

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Optas LLC's AZN Position: Q2 2026 in Review

Optas LLC increased its AstraZeneca (AZN) stake by 0.29% in Q2 2026, buying an estimated $3.76K and bringing the position to 6,859 shares worth $1.3M. The position accounts for 0.18% of the portfolio, ranked #65.

Optas LLC first reported a position in AZN in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.35M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Optas LLC held 6,859 shares of AstraZeneca worth $1.3M as of Q2 2026.
  • Optas LLC bought 20 AstraZeneca shares in Q2 2026, an estimated $3.76K.
  • AstraZeneca made up 0.18% of Optas LLC's portfolio in Q2 2026, its #65 holding.
  • Optas LLC first reported a position in AstraZeneca in Q3 2020 and has held it in 20 quarters since.
  • Optas LLC's AstraZeneca position peaked at $1.35M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.